1.
Vasu S, Altman JK, Uy GL, Tallman MS, Gojo I, Lozanski G, Burkard U, Osswald A, James P, RĂ¼ter B, Blum W. A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia. haematol [Internet]. 2021Dec.2 [cited 2022Oct.6];107(3):770-3. Available from: https://haematologica.org/article/view/haematol.2020.274118